NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, November 13th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. View Baxter International's Dividend History.

Baxter International announced that its board has authorized a share repurchase program on Tuesday, November 13th 2018, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 6.1% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) announced its earnings results on Thursday, January, 31st. The medical instruments supplier reported $0.78 EPS for the quarter, beating the Zacks' consensus estimate of $0.73 by $0.05. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a return on equity of 18.46% and a net margin of 14.60%. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Baxter International.

Baxter International issued an update on its FY19 earnings guidance on Thursday, January, 31st. The company provided earnings per share guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.

16 brokerages have issued 1 year target prices for Baxter International's shares. Their forecasts range from $70.00 to $85.00. On average, they expect Baxter International's share price to reach $76.5625 in the next twelve months. This suggests a possible upside of 4.3% from the stock's current price. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Press coverage about BAX stock has been trending neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Baxter International earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Penumbra (PEN), ICU Medical (ICUI), Insulet (PODD), Novocure (NVCR) and Globus Medical (GMED).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.29%), Third Point LLC (5.26%), Northern Trust Corp (1.62%), Geode Capital Management LLC (1.21%), Harris Associates L P (1.05%) and Standard Life Aberdeen plc (0.98%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Two Sigma Advisers LP, Harris Associates L P, Canada Pension Plan Investment Board, BlackRock Inc., Standard Life Aberdeen plc, Smith Asset Management Group LP and Prudential Financial Inc.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, State of Tennessee Treasury Department, California Public Employees Retirement System, Mackenzie Financial Corp, State of New Jersey Common Pension Fund D, Eaton Vance Management, Mawer Investment Management Ltd. and Bessemer Group Inc.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $73.43.

Baxter International has a market capitalization of $39.08 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]